Epilepsy. Epilepsy and recurrent seizures
Conditions
Interventions
The self-management program will begin for the test group. this program will be implemented by face-to-face for patients in two stages: identification of the disease and implementation of drug compli
Sponsors
Jahrom University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Patients have a definite diagnosis of epilepsy. Epileptic patients 18-50 years old referred to the epilepsy department of Namazi Hospital in Shiraz. Have at least one seizure attack (including all types of seizures, including general, focal, and seizures with unknown causes) in the last trimester. history of at least 2 years of epilepsy (to determine whether epilepsy is not resistant to treatment) Patients selected should be treated with at least one anticonvulsant. Have the desire and ability to learn (read and write literacy) self-management program and its application. Having the desire and satisfaction to participate in the intervention.
Exclusion criteria
Exclusion criteria: Patients who have undergone vagal nerve stimulation surgery or callosotomy and whose seizures have been controlled by surgery. Patients with epilepsy resistant to treatment. Patients whose seizures are controlled and do not take medication. Having a specific physical illness (heart disease, gastrointestinal disease, respiratory illness, etc.) and mental illness (depression, bipolar disorder, psychosis, panic disorder, etc.) before or during an acute illness while participating in the intervention That will affect the outcome of the study by not cooperating with the patient. Lack of desire and satisfaction to continue the intervention. Patients who have participated in the self-management training program for the past 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Increased pharmacological adherence of epilepsy patients. Timepoint: Before the intervention - two months after the intervention. Method of measurement: Medication adherence questionnaire Morisky (Score less than 6; low compliance level, score 6 to less than 8; moderate compliance level and score 8; high compliance level). | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduce the number of seizures. Timepoint: Two months after the intervention. Method of measurement: Self-efficacy assessment questionnaire in patients with epilepsy.;Cntrol the effects of the disease. Timepoint: Two months after the intervention. Method of measurement: Self-efficacy assessment questionnaire in patients with epilepsy. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFateme Mousavi Moghaddam
Jahrom University of Medical Sciences
Outcome results
None listed